공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 실험실 자동화 소프트웨어 시장 : 성장, 동향, 예측(2019-2024년)

Lab Automation Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 01월 상품 코드 393791
페이지 정보 영문
가격
US $ 4,250 ₩ 4,791,000 PDF (Single User License)
US $ 4,750 ₩ 5,354,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,763,000 PDF (Site License)
US $ 7,500 ₩ 8,454,000 PDF (Corporate License)


세계의 실험실 자동화 소프트웨어 시장 : 성장, 동향, 예측(2019-2024년) Lab Automation Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 실험실 자동화 소프트웨어(Lab Automation Software) 시장은 2019-2024년 5.23%의 CAGR로 성장할 전망입니다.

세계의 실험실 자동화 소프트웨어 시장에 대해 조사했으며, 시장 동향 및 기회, 성장 및 저해요인, 소프트웨어·용도의 분야·지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 시장의 정의
  • 조사 주요 결과

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

  • 시장 개요
  • 밸류체인/공급망 분석
  • 업계의 매력 - Porter's Five Forces 분석
    • 공급업체의 교섭력
    • 바이어/소비자의 교섭력
    • 신규 진출의 위협
    • 대체 제품의 위협
    • 업계내 경쟁

제5장 기술 개요

제6장 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 저해요인

제7장 시장 세분화

  • 소프트웨어별
    • 실험실 정보 관리 시스템(LIMS)
    • 실험실 정보 시스템(LIS)
    • 크로마토그래피 데이터 시스템(CDS)
    • 전자 랩 노트북(ELN)
    • 과학 데이터 관리 시스템(SDMS)
  • 용도의 분야별
    • Drug Discovery
    • 게노믹스
    • 프로테오믹스
    • 임상 진단
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타

제8장 경쟁 구도

  • 기업 개요
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Hudson Robotics
    • Becton, Dickinson & Company
    • Synchron Lab Automation
    • Agilent Technologies
    • Siemens Healthcare
    • Tecan Group Ltd
    • Perkinelmer Inc.
    • Bio-Rad Laboratories Inc.
    • Roche Holding AG
    • Eppendorf AG
    • Shimadzu Corporation

제9장 투자 분석

제10장 시장 기회 및 향후 전망

KSA 19.07.26

The lab automation software market was valued at USD 1078.4 million in 2020 and is expected to reach USD 1621.15 million by 2026, at a CAGR of 7.15% over the forecast period 2021 - 2026. Automation is used in a wide variety of life science applications ranging from proteomics to systems biology. Automation of routine laboratory procedures for the use of dedicated workstations and software to program instruments allows associate scientists and technicians to think creatively about the implications of their experimentation and to design useful follow-up projects or develop alternative approaches to their work instead of spending their days performing tasks of tedious repetition.

  • The integration of robotics and automation is rapidly increasing, owing to the enhanced productivity and mitigated operational cost for laboratories. It is likely to boost the market growth over the forecast period.
  • The progress in understanding and the discovery of the nature of life, including the polymerase chain reaction (PCR), splice genes, means of sequencing are on the rise, which may propel the market growth.
  • The cost to set lab automation module, including software, is on the higher side and discourages small enterprises. This factor is expected to hamper the market growth over the forecast period.

Key Market Trends

Laboratory Information Management System Expected to Have Largest Market Share

  • The laboratory information management system industry exhibited robust growth over the past five years as laboratories grappled with an increase in sample volumes, partly due to the increased demand for diagnostic testing from the burgeoning elderly population.
  • Industry operators have particularly focused on developing software that assists with operational issues, such as data security and regulatory compliance. This market is driven by certain factors, such as the rising pressure to comply with regulations, a growing need to integrate healthcare systems, a shift from legacy systems to commercial off-the-shelf LIMS solutions, and technological advancements in LIMS products.
  • Moreover, the funding for tests, such as genome and DNA has led to an increase in the laboratory information and data. Therefore, the rising practice of genome study is favoring the market growth. Associated advantages, such as high precision and elimination of manual data transcription error are also anticipated to provide a boost to the market.

North America Expected to Hold the Largest Market Share

  • The United States dominates the North American market and is the major revenue contributor in the region. The large share in this region can be attributed to the growing applications of lab automation in drug development and clinical laboratory functions. The rise in the number of clinical and pre-clinical studies worldwide has made the need for speed in the analysis of samples imperative, making automation one of the key components, contributing toward the growth of the market.
  • Strict regulations by the United States government and the FDA, along with the growing demand in the diagnostic market and the increasing usage of the discovery and research labs, owing to the rising presence of various diseases, such as cardiovascular and neurological diseases, in the region, has fuelled the growth of the market in this region.

Competitive Landscape

The lab automation software market is neither highly competitive nor does it have a limited number of players. There are other newer technologies in the pipeline through which routine laboratory processes, such as testing and screening are automated. Automation tools can process concurrent requests in real-time, showing marked improvement in productivity and throughput.

  • July 2017 - Thermo Fisher Scientific announced two innovative technologies (ISQ EC Single Quadrupole mass spectrometer, MAbPac RP 1mm columns). These are expected to increase the analytical analysis.
  • May 2017 - Seegene partnered with Thermo Fisher Scientific to bring its diagnostic assays to the US market. The agreement witnessed the South Korean molecular diagnostics player file for FDA clearance for its products, which was at the same time as Thermo Fisher sought a regulatory nod to run the diagnostics on its equipment.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Market Definition
  • 1.4 Key Findings of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Value Chain / Supply Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 TECHNOLOGY SNAPSHOT

6 MARKET DYNAMICS

  • 6.1 Market Drivers
    • 6.1.1 Increasing Research and Development by Pharmaceutical and Biotech Companies
    • 6.1.2 Growing Demand from Drug Discovery and Genomics
  • 6.2 Market Restraints
    • 6.2.1 Higher Initial Setup Costs Can be Expensive for Overall Module

7 MARKET SEGMENTATION

  • 7.1 By Software
    • 7.1.1 Laboratory Information Management System (LIMS)
    • 7.1.2 Laboratory Information System (LIS)
    • 7.1.3 Chromatography Data System (CDS)
    • 7.1.4 Electronic Lab Notebook (ELN)
    • 7.1.5 Scientific Data Management System (SDMS)
  • 7.2 By Field of Application
    • 7.2.1 Drug Discovery
    • 7.2.2 Genomics
    • 7.2.3 Proteomics
    • 7.2.4 Clinical Diagnostics
    • 7.2.5 Other Applications
  • 7.3 Geography
    • 7.3.1 North America
    • 7.3.2 Europe
    • 7.3.3 Asia-Pacific
    • 7.3.4 Rest of the world

8 COMPETITIVE LANDSCAPE

  • 8.1 Company Profiles
    • 8.1.1 Thermo Fisher Scientific
    • 8.1.2 Danaher Corporation
    • 8.1.3 Hudson Robotics
    • 8.1.4 Becton, Dickinson & Company
    • 8.1.5 Synchron Lab Automation
    • 8.1.6 Agilent Technologies
    • 8.1.7 Siemens Healthcare
    • 8.1.8 Tecan Group Ltd
    • 8.1.9 Perkinelmer Inc.
    • 8.1.10 Bio-Rad Laboratories Inc.
    • 8.1.11 Roche Holding AG
    • 8.1.12 Eppendorf AG
    • 8.1.13 Shimadzu Corporation

9 INVESTMENT ANALYSIS

10 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q